| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e2ba784a11bf94f0d7af0b295a8c05 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 |
| filingDate |
2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64f85aec12846690ecf89a9cf3c9da3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_489c8c34b5c21a500bd6418022c10ca4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1ff651dc049f2308b739609646576b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f1889c62b205f140ebed109e66d5605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ae6445a63ac82f20de953757c925e08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3c1a89fe47f7605d69fad3624f79611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8edea921c3678bccc01b82900e870c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b7330558e4fdd977f438c712c0b6742 |
| publicationDate |
2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2016200468-B2 |
| titleOfInvention |
High purity cyclopeptide compound as well as preparation method and use thereof |
| abstract |
Abstract Disclosed is a high purity cyclopeptide compound, the chemical structure of which is represented by Formula (I). :H H N 'OH N HNH .tL H H3Cw- OktH H HO ) z H R represents H or a cation capable of forming a pharmaceutically acceptable salt, the purity being greater than or equal to 99.0%. Further disclosed are a 10 preparation method and use of the high purity cyclopeptide compound. 73465451 (GHMatters) P98493.AU.1 MICHELES 27/01/16 1 /-' Fig. 1 - -r --1 - --- Fig. 2 5903 2 391I (GH~latters) P98A93 AU NIOL1 'H'A |
| priorityDate |
2012-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |